The danger model: Questioning an unconvincing theory

Immunology and Cell Biology

Volumn 94, Issue 2, 2016, Pages 164-168

  Józefowski, Szczepan ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DANGER ASSOCIATED MOLECULAR PATTER; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PATTERN RECOGNITION RECEPTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ARTICLE; CELL DAMAGE; CHIMERA; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOSTIMULATION; INFECTION; NONHUMAN; THEORETICAL MODEL; ANIMAL; BIOLOGICAL MODEL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNITY; IMMUNOLOGY;

ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE SYSTEM; IMMUNITY; MODELS, IMMUNOLOGICAL; RECEPTORS, PATTERN RECOGNITION;

EID: 84983134421     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2015.68     Document Type: Article

References (73)

1. Janeway CA. Approaching the asymptote Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989; 54: 1-13.
2. Medzhitov R, Janeway C. Innate immune recognition: mechanisms and pathways. Immunol Rev 2000; 173: 89-97.
3. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994; 12: 991-1045.
4. Matzinger P. The danger model: a renewed sense of self. Science 2002; 296: 301-305.
5. Schaefer L. Complexity of danger: the diverse nature of damage-associated molecular patterns. J Biol Chem 2014; 289: 35237-35245.
6. Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 2009; 458: 1191-1195.
7. JinMS, KimSE, Heo JY, LeeME, KimHM, Paik SG et al. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007; 130: 1071-1082.
8. Kang JY, Nan X, Jin MS, Youn SJ, Ryu YH, Mah S et al. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 2009; 31: 873-884.
9. Gao B, Tsan MF. Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor from murine macrophages. J Biol Chem 2003; 278: 22523-22529.
10. Bausinger H, Lipsker D, Ziylan U, Manié S, Briand JP, Cazenave JP et al. Endotoxin-free heat-shock protein 70 fails to induce APC activation. Eur J Immunol 2002; 32: 3708-3713.
11. Hreggvidsdottir HS, Ostberg T, Wähämaa H, Schierbeck H, Aveberger AC, Klevenvall L et al. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J Leukoc Biol 2009; 86: 655-662.
12. Gasic-Milenkovic J, Dukic-Stefanovic S, Deuther-Conrad W, Gärtner U, Münch G.-Amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon-and 'advanced glycation endproducts' in a murine microglia cell line. Eur J Neurosci 2003; 17: 813-821.
13. Ye Z, Gan YH. Flagellin contamination of recombinant heat shock protein 70 is responsible for its activity on T cells. J Biol Chem 2007; 282: 4479-4484.
14. Lee JD, Kato K, Tobias PS, Kirkland TN, Ulevitch RJ. Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein. J Exp Med 1992; 175: 1697-1705.
15. Ranoa DR, Kelley SL, Tapping RI. Human lipopolysaccharide-binding protein (LBP) and CD14 independently deliver triacylated lipoproteins to Toll-like receptor 1 (TLR1) and TLR2 and enhance formation of the ternary signaling complex. J Biol Chem2013; 288: 9729-9741.
16. Youn JH, Kwak MS, Wu J, Kim ES, Ji Y, Min HJ et al. Identification of lipopolysaccharide-binding peptide regions within HMGB1 and their effects on subclinical endotoxemia in a mouse model. Eur J Immunol 2011; 41: 2753-2762.
17. Habich C, Kempe K, van der Zee R, Rümenapf R, Akiyama H, Kolb H et al. Heat shock protein 60: specific binding of lipopolysaccharide. J Immunol 2005; 174: 1298-1305.
18. Sorci G, Giovannini G, Riuzzi F, Bonifazi P, Zelante T, Zagarella S et al. The danger signal S100B integrates pathogen-and danger-sensing pathways to restrain inflammation. PLoS Pathog 2011; 7: e1001315.
19. Motzkus D, Schulz-Maronde S, Heitland A, Schulz A, Forssmann WG, Jübner M et al. The novel-defensin DEFB123 prevents lipopolysaccharide-mediated effects in vitro and in vivo. FASEB J 2006; 20: 1701-1702.
20. Youn JH, Oh YJ, Kim ES, Choi JE, Shin JS. High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-production in human monocytes. J Immunol 2008; 180: 5067-5074.
21. Kwak MS, Lim M, Lee YJ, Lee HS, Kim YH, Youn JH et al. HMGB1 binds to lipoteichoic acid and enhances TNF-and IL-6 production through HMGB1-mediated transfer of lipoteichoic acid to CD14 and TLR2. J Innate Immun 2015; 7: 405-416.
22. Warger T, Hilf N, Rechtsteiner G, Haselmayer P, Carrick DM, Jonuleit H et al. Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responses. J Biol Chem 2006; 281: 22545-22553.
23. Dentener MA, Von Asmuth EJ, Francot GJ, Marra MN, Buurman WA. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide. J Immunol 1993; 151: 4258-4265.
24. Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants J Leukoc Biol 2010; 87: 989-999.
25. Tsan MF, Gao B. Pathogen-associated molecular pattern contamination as putative endogenous ligands of Toll-like receptors. J Endotoxin Res 2007; 13: 6-14.
26. Brown GD, Gordon S. Immune recognition. A new receptor for-glucans. Nature 2001; 413: 36-37.
27. Yonekawa A, Saijo S, Hoshino Y, Miyake Y, Ishikawa E, Suzukawa M et al. Dectin-2 is a direct receptor for mannose-capped lipoarabinomannan of mycobacteria. Immunity 2014; 41: 402-413.
28. Biedro R, Konopiski MK, Marcinkiewicz J, Józefowski S. Oxidation by neutrophilsderived HOCl increases immunogenicity of proteins by converting them into ligands of several endocytic receptors involved in antigen uptake by dendritic cells and macrophages. PLoS One 2015; 10: e0123293.
29. Germani A, Limana F, Capogrossi MC. Pivotal advances: high-mobility group box 1 protein-a cytokine with a role in cardiac repair. J Leukoc Biol 2007; 81: 41-45.
30. Straino S, Di Carlo A, Mangoni A, De Mori R, Guerra L, Maurelli R et al. High-mobility group box 1 protein in human and murine skin: involvement in wound healing. J Invest Dermatol 2008; 128: 1545-1553.
31. De Mori R, Straino S, Di Carlo A, Mangoni A, Pompilio G, Palumbo R et al. Multiple effects of high mobility group box protein 1 in skeletal muscle regeneration. Arterioscler Thromb Vasc Biol 2007; 27: 2377-2383.
32. Riuzzi F, Sorci G, Sagheddu R, Donato R. HMGB1-RAGE regulates muscle satellite cell homeostasis through p38-MAPK-and myogenin-dependent repression of Pax7 transcription. J Cell Sci 2012; 125: 1440-1454.
33. van Zoelen MA, Wieland CW, van der Windt GJ, Florquin S, Nawroth PP, Bierhaus A et al. Receptor for advanced glycation end products is protective during murine tuberculosis. Mol Immunol 2012; 52: 183-189.
34. van Zoelen MA, Schmidt AM, Florquin S, Meijers JC, de Beer R, de Vos AF et al. Receptor for advanced glycation end products facilitates host defense during Escherichia coli-induced abdominal sepsis in mice. J Infect Dis 2009; 200: 765-773.
35. Murshid A, Gong J, Calderwood SK. The role of heat shock proteins in antigen cross presentation. Front Immunol 2012; 3: 63.
36. Józefowski S, Biedro R, Sróttek M, Chadziska M, Marcinkiewicz J. The class A scavenger receptor SR-A/CD204 and the class B scavenger receptor CD36 regulate immune functions of macrophages differently. Innate Immun 2014; 20: 826-847.
37. Johnson BJ, Le TT, Dobbin CA, Banovic T, Howard CB. Flores FeM et al. Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator production. J Biol Chem 2005; 280: 4037-4047.
38. Spiering R, van der Zee R, Wagenaar J, van Eden W, Broere F. Mycobacterial and mouse HSP70 have immuno-modulatory effects on dendritic cells. Cell Stress Chaperones 2013; 18: 439-446.
39. Chu AJ. Blood coagulation as an intrinsic pathway for proinflammation: a mini review. Inflamm Allergy Drug Targets 2010; 9: 32-44.
40. Syrovets T, Lunov O, Simmet T. Plasmin as a proinflammatory cell activator. J Leukoc Biol 2012; 92: 509-519.
41. Kataoka H, Kono H, Patel Z, Rock KL. Evaluation of the contribution of multiple DAMPs and DAMP receptors in cell death-induced sterile inflammatory responses. PLoS One 2014; 9: e104741.
42. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; 464: 104-107.
43. McDonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, Waterhouse CC et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 2010; 330: 362-366.
44. Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 2007; 13: 851-856.
45. Munõz-Planillo R, Kuffa P, Martínez-Colón G, Smith BL, Rajendiran TM, Núñez G. K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 2013; 38: 1142-1153.
46. Robbins GR, Wen H, Ting JP. Inflammasomes and metabolic disorders: old genes in modern diseases. Mol Cell 2014; 54: 297-308.
47. Kono H, Orlowski GM, Patel Z, Rock KL. The IL-1-dependent sterile inflammatory response has a substantial caspase-1-independent component that requires cathepsin C. J Immunol 2012; 189: 3734-3740.
48. Inoue Y, Shirasuna K, Kimura H, Usui F, Kawashima A, Karasawa T et al. NLRP3 regulates neutrophil functions and contributes to hepatic ischemia-reperfusion injury independently of inflammasomes. J Immunol 2014; 192: 4342-4351.
49. Shigeoka AA, Mueller JL, Kambo A, Mathison JC, King AJ, Hall WF et al. An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemiareperfusion injury. J Immunol 2010; 185: 6277-6285.
50. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D et al. Cutting edge: NF-B activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 2009; 183: 787-791.
51. Eguchi K, Manabe I. Toll-like receptor, lipotoxicity and chronic inflammation: the pathological link between obesity and cardiometabolic disease. J Atheroscler Thromb 2014; 21: 629-639.
52. Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 2010; 11: 155-161.
53. Hamilton TA, Ma GP, Chisolm GM. Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-mRNA in stimulated murine peritoneal macrophages. J Immunol 1990; 144: 2343-2350.
54. Fong LG, Fong TA, Cooper AD. Inhibition of lipopolysaccharide-induced interleukin-1 mRNA expression in mouse macrophages by oxidized low density lipoprotein. J Lipid Res 1991; 32: 1899-1910.
55. Thai SF, Lewis JG, Williams RB, Johnson SP, Adams DO. Effects of oxidized LDL on mononuclear phagocytes: inhibition of induction of four inflammatory cytokine gene RNAs, release of NO, and cytolysis of tumor cells. J Leukoc Biol 1995; 57: 427-433.
56. Kannan Y, Sundaram K, Aluganti Narasimhulu C, Parthasarathy S, Wewers MD. Oxidatively modified low density lipoprotein (LDL) inhibits TLR2 and TLR4 cytokine responses in human monocytes but not in macrophages. J Biol Chem 2012; 287: 23479-23488.
57. Kunjathoor VV, Febbraio M, Podrez EA, Moore KJ, Andersson L, Koehn S et al. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem 2002; 277: 49982-49988.
58. Zhao Z, Wu Y, Cheng M, Ji Y, Yang X, Liu P et al. Activation of Th17/Th1 and Th1, but not Th17, is associated with the acute cardiac event in patients with acute coronary syndrome. Atherosclerosis 2011; 217: 518-524.
59. Mullick AE, Tobias PS, Curtiss LK. Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest 2005; 115: 3149-3156.
60. Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 2004; 101: 10679-10684.
61. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001; 103: 1064-1070.
62. Wiedermann CJ, Kiechl S, Dunzendorfer S, Schratzberger P, Egger G, Oberhollenzer F et al. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol 1999; 34: 1975-1981.
63. Pussinen PJ, Tuomisto K, Jousilahti P, Havulinna AS, Sundvall J, Salomaa V. Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler Thromb Vasc Biol 2007; 27: 1433-1439.
64. Bhanji S, Williams B, Sheller B, Elwood T, Mancl L. Transient bacteremia induced by toothbrushing a comparison of the Sonicare toothbrush with a conventional toothbrush. Pediatr Dent 2002; 24: 295-299.
65. Erridge C, Attina T, Spickett CM, Webb DJ. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 2007; 86: 1286-1292.
66. Erridge C. Diet, commensals and the intestine as sources of pathogen-associated molecular patterns in atherosclerosis, type 2 diabetes and non-alcoholic fatty liver disease. Atherosclerosis 2011; 216: 1-6.
67. Maitra U, Li L. Molecular mechanisms responsible for the reduced expression of cholesterol transporters from macrophages by low-dose endotoxin. Arterioscler Thromb Vasc Biol 2013; 33: 24-33.
68. He LZ, Crocker A, Lee J, Mendoza-Ramirez J, Wang XT, Vitale LA et al. Antigenic targeting of the human mannose receptor induces tumor immunity. J Immunol 2007; 178: 6259-6267.
69. Marshall FA, Pearce EJ. Uncoupling of induced protein processing from maturation in dendritic cells exposed to a highly antigenic preparation from a helminth parasite. J Immunol 2008; 181: 7562-7570.
70. Tagliani E, Guermonprez P, Sepúlveda J, López-Bravo M, Ardavín C, Amigorena S et al. Selection of an antibody library identifies a pathway to induce immunity by targeting CD36 on steady-state CD8+ dendritic cells. J Immunol 2008; 180: 3201-3209.
71. Jaiswal AI, Dubey C, Swain SL, Croft M. Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals. Int Immunol 1996; 8: 275-285.
72. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996; 184: 747-752.
73. Nádházi Z, Takáts A, Offenmüller K, Bertók L. Plasma endotoxin level of healthy donors. Acta Microbiol Immunol Hung 2002; 49: 151-157.